Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
ABT-957 Alzheimer's Disease (Phase 1) AbbVie Other Small Molecule
Allopregnanolone 3α,5α-tetrahydroprogesterone,
3α-hydroxy-5α-pregnan-20-one
Alzheimer's Disease (Phase 1) Other Neurotransmitters, Other Small Molecule
GC 021109 Alzheimer's Disease (Phase 1) GliaCure Inflammation Small Molecule
GLN-1062 Memogain Alzheimer's Disease (Phase 1) Galantos Pharma, Neurodyn Cholinergic System Small Molecule
GSK2647544 GSK-2647544 Alzheimer's Disease (Phase 1) GlaxoSmithKline (GSK) Cholesterol Small Molecule
PF-05251749 Alzheimer's Disease (Phase 1) Pfizer Unknown Small Molecule
PF-06648671 Alzheimer's Disease (Phase 1) Pfizer Amyloid-Related Small Molecule
PF-06751979 Alzheimer's Disease (Phase 1) Pfizer Unknown Small Molecule
S-Equol Aus-131 Alzheimer's Disease (Phase 1) Ausio Pharmaceuticals, LLC Other Small Molecule
SUVN-G3031 Alzheimer's Disease (Phase 1) Suven Life Sciences Ltd Cholinergic System, Other Neurotransmitters Small Molecule
TPI 287 Alzheimer's Disease (Phase 1), Corticobasal Degeneration (Phase 1), Progressive Supranuclear Palsy (Phase 1) Cortice Biosciences Tau Small Molecule